CEP: Career Enhancement Program

CEP：职业提升计划

基本信息

批准号：
10713059
负责人：
FRANCESMARY MODUGNO
金额：
$ 7.39万
依托单位：
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
依托单位国家：
美国
项目类别：
财政年份：
2023
资助国家：
美国
起止时间：
2023-09-01 至 2028-08-31
项目状态：
未结题

来源：
https://reporter.nih.gov/project-details/10713059
关键词：
Advocate Applications Grants Award Basic Science Bioinformatics Biological Models Biometry Cancer Center Cancer Research Project Career Mobility Clinic Clinical Clinical Investigator Clinical Research Clinical Sciences Clinical Trials Collaborations Communities Dedications Department chair Detection Development Disabled Persons Discipline of obstetrics Disease Ensure Environment Epidemiology Equilibrium Ethnic Population Extramural Activities Faculty Feedback Fostering Funding Future Generations Goals Group Meetings Growth Gynecology Hematology Home Human Individual Institution Investments Joints Leadership Malignant Neoplasms Malignant neoplasm of ovary Medicine Mentors Minority-Serving Institution Mission Morehouse School of Medicine Nursing Faculty Oncology Ovarian Patients Peer Review Performance Population Sciences Positioning Attribute Postdoctoral Fellow Preparation Prevention Procedures Process Program Development Puerto Rico Reproductive Sciences Research Research Institute Research Personnel Research Project Grants Research Training Resources Science Scientist Series Services Specimen Structure System Target Populations Tissues Training Translational Research Translations Underrepresented Minority Underrepresented Populations United States National Institutes of Health Universities Woman anticancer research cancer care career career development design experience improved insight meetings member mid-career faculty next generation outreach professor programs racial population recruit success translational cancer research translational impact translational scientist working group

项目摘要

PROJECT SUMMARY – CAREER ENHANCEMENT PROGRAM (CEP) The mission of the Hillman Cancer Center (HCC) Ovarian Cancer (OvCa) SPORE Career Enhancement Program (CEP) is to foster the development of independent translational ovarian cancer researchers who will impact ovarian cancer care. This includes supporting not only outstanding early career scientists, but also experienced investigators wishing to transition their careers into translational ovarian cancer research, or clinical investigators well versed in the design and performance of clinical trials who wish to broaden their translational research experience. The HCC OvCa SPORE is fully committed to diversity and has established collaborations with external institutions to increase the participation of under-represented scientists in the CEP. The CEP will provide funding, access to SPORE resources, and a supportive research environment. Proposals will be solicited annually and use an NIH-style peer-review scoring system to prioritize projects for funding. Projects will be funded for 2 years at $50,000 per year, with half the monies coming from CEP and the other half from institutional funds. The second year of funding will be contingent on progress made during the first year. The CEP Co-Directors, SPORE Executive Committee, and SPORE investigators will participate in the review process, together with Patient Advocates and ad hoc expert revewers when necessary. The final selection of awardees will be made following a second tier review involving the SPORE Internal Advisory Board (IAB). CEP awardees will be matched with an appropriate SPORE mentor and provided full access to the HCC OvCa SPORE Core resources, including tissue specimens and bioinformatics/biostatistical support. The CEP will directly facilitate career development through: i) constructive proposal review and feedback; ii) research training with a mentor chosen from among diverse faculty with broad expertise and experience in academic career development; and iii) access to development programs, including monthly ovarian cancer research group meetings, monthly SPORE meetings, the annual HCC and Magee Womens Research Institute retreats, and the annual SPORE retreat. The CEP will track progress of awardees and ensure that they obtain any needed services from SPORE Cores, and make certain that they are fully integrated into the SPORE program. Awardees will meet regularly with mentors and will be encouraged to participate in courses in clinical and translational research to further enhance their career development. Projects that show the greatest likelihood of impact and translation to the clinic can evolve into future full SPORE projects. Awardees will also be advised as appropriate in the preparation of grant applications for funding outside the SPORE mechanism and given access to SPORE resources to aid in this endeavor. These procedures were developed via a previous joint P50 award that resulted in a 12-fold return on investment for CEP projects. Ultimately, the CEP provides a vital mechanism for achieving the SPORE’s goal of developing the next generation of ovarian cancer researchers committed to overcoming this deadly disease.

项目摘要 – 职业提升计划 (CEP) Hillman 癌症中心 (HCC) 卵巢癌 (OvCa) SPORE 职业提升的使命计划（CEP）旨在促进独立转化卵巢癌研究人员的发展，他们将这不仅包括支持杰出的早期职业科学家，还包括支持卵巢癌治疗。希望将其职业生涯转变为转化性卵巢癌研究的经验丰富的研究人员，或精通临床试验的设计和执行并希望扩大其研究范围的临床研究人员 HCC OvCa SPORE 完全致力于多样性并已建立了转化研究经验。与外部机构合作，以增加代表性不足的科学家对 CEP 的参与。 CEP 将提供资金、SPORE 资源和支持性研究环境。每年都会进行征集，并使用 NIH 风格的同行评审评分系统来确定资助项目的优先顺序。项目的资助期限为 2 年，每年 50,000 美元，其中一半资金来自 CEP，另一半来自 CEP 第二年的资金将取决于第一年取得的进展。 CEP 联合主任、SPORE 执行委员会和 SPORE 调查员将参加。必要时与患者权益倡导者和特设专家评审员一起进行评审过程。获奖者的选择将在涉及 SPORE 内部咨询的第二级审查后进行董事会 (IAB) 将为 CEP 获奖者匹配一位合适的 SPORE 导师，并提供充分的访问权限。 HCC OvCa SPORE 核心资源，包括组织标本和生物信息学/生物统计支持。 CEP 将通过以下方式直接促进职业发展： i) 建设性提案审查和反馈； ii) 由具有广泛专业知识和经验的不同教师中选出的导师进行研究培训学术职业发展；以及 iii) 参与发展计划，包括每月卵巢癌研究小组会议、每月 SPORE 会议、年度 HCC 和 Magee 妇女研究所静修会和年度 SPORE 静修会将跟踪获奖者的进展并确保他们获得奖励。 SPORE 核心所需的任何服务，并确保它们完全集成到 SPORE 中获奖者将定期与导师会面，并被鼓励参加临床课程。和转化研究，以进一步促进他们的职业发展。影响和转化为临床的可能性可能会演变成未来完整的 SPORE 项目。在准备 SPORE 机制之外资助的赠款申请时酌情提供建议并获得 SPORE 资源的访问权以帮助实现这一目标。这些程序是通过一个项目开发的。此前联合 P50 奖项为 CEP 项目带来了 12 倍的投资回报。为实现 SPORE 发育下一代卵巢的目标提供了重要机制癌症研究人员致力于克服这种致命疾病。